Tci Gene Inc.(TW:6879)
NT$35.500.00 (0.00%)
TW:6879
Tci Gene Inc. financials statements
NT$35.50
At close:0.00 (0.00%)
Tci Gene Inc. (6879) Financial Statements
Tci Gene Inc. Financial Overview
Tci Gene Inc.'s market cap is currently NT$939.28M. The company's EPS TTM is NT$1.92; its P/E ratio is 18.49; and it has a dividend yield of 5.63%. Tci Gene Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 273.61M | NT$ 347.54M | NT$ 333.86M | NT$ 424.02M | NT$ 432.22M |
| Gross Profit | NT$ 152.59M | NT$ 204.07M | NT$ 174.62M | NT$ 243.36M | NT$ 239.43M |
| Operating Income | NT$ 20.93M | NT$ 52.50M | NT$ 5.93M | NT$ 90.56M | NT$ 113.57M |
| EBITDA | NT$ 32.91M | NT$ 81.85M | NT$ 25.89M | NT$ 121.16M | NT$ 155.43M |
| Net Income | NT$ 40.57M | NT$ 56.31M | NT$ 11.67M | NT$ 72.14M | NT$ 92.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 831.73M | NT$ 836.93M | NT$ 899.65M | NT$ 937.74M | NT$ 330.19M |
| Total Assets | NT$ 1.01B | NT$ 1.10B | NT$ 1.17B | NT$ 1.16B | NT$ 560.31M |
| Total Debt | NT$ 7.10M | NT$ 775.00K | NT$ 6.79M | NT$ 2.47M | NT$ 8.27M |
| Net Debt | NT$ -243.59M | NT$ -97.65M | NT$ -689.25M | NT$ -930.26M | NT$ -317.92M |
| Total Liabilities | NT$ 98.64M | NT$ 101.29M | NT$ 155.55M | NT$ 143.17M | NT$ 169.44M |
| Stockholders' Equity | NT$ 890.51M | NT$ 974.73M | NT$ 986.51M | NT$ 1.01B | NT$ 380.20M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 150.91M | NT$ 54.30M | NT$ 14.68M | NT$ 95.06M | NT$ 95.76M |
| Operating Cash Flow | NT$ 151.33M | NT$ 56.97M | NT$ 17.85M | NT$ 110.35M | NT$ 119.18M |
| Investing Cash Flow | NT$ 59.68M | NT$ -619.34M | NT$ -203.86M | NT$ -39.99M | NT$ -26.95M |
| Financing Cash Flow | NT$ -59.83M | NT$ -35.52M | NT$ -50.64M | NT$ 535.73M | NT$ 54.61M |
Currency in TWD

